- LCIG Improves Quality of Life, Reduces Symptoms of Parkinson's

 – April 21, 2012  –– 

A recent clinical trial shows that a new form of a common drug used to treat Parkinson's Disease greatly improves the quality of life for patients and reduces the affects of symptoms such as tremors, slowness, stiffness and difficulty walking. The trial was led by Dr. C. Warren Olanow, a Fellow of the American Academy of Neurology and Professor of Neurology and Neuroscience at Mount Sinai School of Medicine in New York.
- Dr. C. Warren Olanow, Professor and Chair Emeritus, Neurology and Neuroscience, Director, Bendheim Parkinson Center, The Mount Sinai Medical Center
Learn more: